EPHA2 and neoplasm: Blocking EphA receptor signaling using soluble EphA2-Fc and EphA3-Fc receptors decreased tumor vascular density, tumor volume and cell proliferation in vivo, suggesting that the soluble receptors inhibited blood vessel recruitment by the tumor [74, 97, 98].